Logo image of DORM

DORMAN PRODUCTS INC (DORM) Stock Fundamental Analysis

NASDAQ:DORM - Nasdaq - US2582781009 - Common Stock

128.17  -1.89 (-1.45%)

Fundamental Rating

6

Taking everything into account, DORM scores 6 out of 10 in our fundamental rating. DORM was compared to 83 industry peers in the Automobile Components industry. Both the health and profitability get an excellent rating, making DORM a very profitable company, without any liquidiy or solvency issues. DORM has a decent growth rate and is not valued too expensively. With these ratings, DORM could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

DORM had positive earnings in the past year.
In the past year DORM had a positive cash flow from operations.
DORM had positive earnings in each of the past 5 years.
In the past 5 years DORM always reported a positive cash flow from operatings.
DORM Yearly Net Income VS EBIT VS OCF VS FCFDORM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

1.2 Ratios

The Return On Assets of DORM (7.86%) is better than 91.57% of its industry peers.
DORM's Return On Equity of 15.05% is amongst the best of the industry. DORM outperforms 92.77% of its industry peers.
DORM's Return On Invested Capital of 11.76% is amongst the best of the industry. DORM outperforms 92.77% of its industry peers.
The Average Return On Invested Capital over the past 3 years for DORM is in line with the industry average of 9.42%.
The 3 year average ROIC (9.08%) for DORM is below the current ROIC(11.76%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.86%
ROE 15.05%
ROIC 11.76%
ROA(3y)6.23%
ROA(5y)7.1%
ROE(3y)12.27%
ROE(5y)12.03%
ROIC(3y)9.08%
ROIC(5y)9.73%
DORM Yearly ROA, ROE, ROICDORM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20

1.3 Margins

DORM has a better Profit Margin (9.43%) than 93.98% of its industry peers.
In the last couple of years the Profit Margin of DORM has declined.
DORM has a better Operating Margin (14.41%) than 97.59% of its industry peers.
DORM's Operating Margin has declined in the last couple of years.
DORM has a better Gross Margin (39.54%) than 93.98% of its industry peers.
DORM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.41%
PM (TTM) 9.43%
GM 39.54%
OM growth 3Y-0.77%
OM growth 5Y-7.46%
PM growth 3Y-11.86%
PM growth 5Y-13.36%
GM growth 3Y0.43%
GM growth 5Y-1.52%
DORM Yearly Profit, Operating, Gross MarginsDORM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

More info and screens

7

2. Health

2.1 Basic Checks

DORM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
DORM has less shares outstanding than it did 1 year ago.
DORM has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, DORM has an improved debt to assets ratio.
DORM Yearly Shares OutstandingDORM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
DORM Yearly Total Debt VS Total AssetsDORM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

DORM has an Altman-Z score of 4.39. This indicates that DORM is financially healthy and has little risk of bankruptcy at the moment.
DORM's Altman-Z score of 4.39 is amongst the best of the industry. DORM outperforms 87.95% of its industry peers.
DORM has a debt to FCF ratio of 3.03. This is a good value and a sign of high solvency as DORM would need 3.03 years to pay back of all of its debts.
With a Debt to FCF ratio value of 3.03, DORM perfoms like the industry average, outperforming 44.58% of the companies in the same industry.
DORM has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
DORM has a Debt to Equity ratio of 0.42. This is in the lower half of the industry: DORM underperforms 67.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 3.03
Altman-Z 4.39
ROIC/WACC1.34
WACC8.81%
DORM Yearly LT Debt VS Equity VS FCFDORM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.3 Liquidity

DORM has a Current Ratio of 2.34. This indicates that DORM is financially healthy and has no problem in meeting its short term obligations.
DORM has a better Current ratio (2.34) than 79.52% of its industry peers.
DORM has a Quick Ratio of 1.16. This is a normal value and indicates that DORM is financially healthy and should not expect problems in meeting its short term obligations.
DORM has a Quick ratio of 1.16. This is in the better half of the industry: DORM outperforms 73.49% of its industry peers.
Industry RankSector Rank
Current Ratio 2.34
Quick Ratio 1.16
DORM Yearly Current Assets VS Current LiabilitesDORM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

More info and screens

6

3. Growth

3.1 Past

DORM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.57%, which is quite impressive.
The Earnings Per Share has been growing slightly by 1.52% on average over the past years.
The Revenue has been growing slightly by 1.70% in the past year.
The Revenue has been growing by 14.66% on average over the past years. This is quite good.
EPS 1Y (TTM)63.57%
EPS 3Y9.48%
EPS 5Y1.52%
EPS Q2Q%40%
Revenue 1Y (TTM)1.7%
Revenue growth 3Y20.87%
Revenue growth 5Y14.66%
Sales Q2Q%3.19%

3.2 Future

DORM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.84% yearly.
The Revenue is expected to grow by 4.47% on average over the next years.
EPS Next Y55.02%
EPS Next 2Y30.05%
EPS Next 3Y22.84%
EPS Next 5YN/A
Revenue Next Year3.5%
Revenue Next 2Y3.49%
Revenue Next 3Y4.47%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DORM Yearly Revenue VS EstimatesDORM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
DORM Yearly EPS VS EstimatesDORM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6 8

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

DORM is valuated rather expensively with a Price/Earnings ratio of 19.69.
Compared to the rest of the industry, the Price/Earnings ratio of DORM is on the same level as its industry peers.
When comparing the Price/Earnings ratio of DORM to the average of the S&P500 Index (28.29), we can say DORM is valued slightly cheaper.
DORM is valuated correctly with a Price/Forward Earnings ratio of 16.69.
Based on the Price/Forward Earnings ratio, DORM is valued a bit more expensive than the industry average as 61.45% of the companies are valued more cheaply.
DORM's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.44.
Industry RankSector Rank
PE 19.69
Fwd PE 16.69
DORM Price Earnings VS Forward Price EarningsDORM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DORM is valued a bit more expensive than the industry average as 72.29% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DORM indicates a slightly more expensive valuation: DORM is more expensive than 67.47% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 22.1
EV/EBITDA 12.9
DORM Per share dataDORM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

DORM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DORM has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as DORM's earnings are expected to grow with 22.84% in the coming years.
PEG (NY)0.36
PEG (5Y)12.95
EPS Next 2Y30.05%
EPS Next 3Y22.84%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DORM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DORMAN PRODUCTS INC

NASDAQ:DORM (1/22/2025, 11:52:10 AM)

128.17

-1.89 (-1.45%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)10-31 2024-10-31/amc
Earnings (Next)N/A N/A
Inst Owners80.36%
Inst Owner Change-0.47%
Ins Owners15.69%
Ins Owner Change-11.64%
Market Cap3.91B
Analysts82
Price Target137.45 (7.24%)
Short Float %1.76%
Short Ratio2.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)31.79%
Min EPS beat(2)25.8%
Max EPS beat(2)37.78%
EPS beat(4)4
Avg EPS beat(4)32.2%
Min EPS beat(4)9.36%
Max EPS beat(4)55.86%
EPS beat(8)4
Avg EPS beat(8)7.6%
EPS beat(12)5
Avg EPS beat(12)4.42%
EPS beat(16)7
Avg EPS beat(16)4.85%
Revenue beat(2)0
Avg Revenue beat(2)-2.5%
Min Revenue beat(2)-3.19%
Max Revenue beat(2)-1.81%
Revenue beat(4)0
Avg Revenue beat(4)-2.55%
Min Revenue beat(4)-3.19%
Max Revenue beat(4)-1.81%
Revenue beat(8)1
Avg Revenue beat(8)-1.64%
Revenue beat(12)4
Avg Revenue beat(12)0.05%
Revenue beat(16)7
Avg Revenue beat(16)0.98%
PT rev (1m)0%
PT rev (3m)14.68%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.34%
EPS NY rev (1m)0%
EPS NY rev (3m)12.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.72%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.29%
Valuation
Industry RankSector Rank
PE 19.69
Fwd PE 16.69
P/S 1.99
P/FCF 22.1
P/OCF 17.84
P/B 3.17
P/tB 7.71
EV/EBITDA 12.9
EPS(TTM)6.51
EY5.08%
EPS(NY)7.68
Fwd EY5.99%
FCF(TTM)5.8
FCFY4.52%
OCF(TTM)7.18
OCFY5.61%
SpS64.54
BVpS40.45
TBVpS16.62
PEG (NY)0.36
PEG (5Y)12.95
Profitability
Industry RankSector Rank
ROA 7.86%
ROE 15.05%
ROCE 15.75%
ROIC 11.76%
ROICexc 12.05%
ROICexgc 20.08%
OM 14.41%
PM (TTM) 9.43%
GM 39.54%
FCFM 8.98%
ROA(3y)6.23%
ROA(5y)7.1%
ROE(3y)12.27%
ROE(5y)12.03%
ROIC(3y)9.08%
ROIC(5y)9.73%
ROICexc(3y)9.38%
ROICexc(5y)10.58%
ROICexgc(3y)15.09%
ROICexgc(5y)14.83%
ROCE(3y)13.5%
ROCE(5y)13.65%
ROICexcg growth 3Y0.77%
ROICexcg growth 5Y-5.08%
ROICexc growth 3Y-10.74%
ROICexc growth 5Y-12.1%
OM growth 3Y-0.77%
OM growth 5Y-7.46%
PM growth 3Y-11.86%
PM growth 5Y-13.36%
GM growth 3Y0.43%
GM growth 5Y-1.52%
F-Score8
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 3.03
Debt/EBITDA 1.52
Cap/Depr 74.31%
Cap/Sales 2.15%
Interest Coverage 7.52
Cash Conversion 64.33%
Profit Quality 95.26%
Current Ratio 2.34
Quick Ratio 1.16
Altman-Z 4.39
F-Score8
WACC8.81%
ROIC/WACC1.34
Cap/Depr(3y)73.79%
Cap/Depr(5y)76.73%
Cap/Sales(3y)1.98%
Cap/Sales(5y)2.07%
Profit Quality(3y)63.94%
Profit Quality(5y)79.58%
High Growth Momentum
Growth
EPS 1Y (TTM)63.57%
EPS 3Y9.48%
EPS 5Y1.52%
EPS Q2Q%40%
EPS Next Y55.02%
EPS Next 2Y30.05%
EPS Next 3Y22.84%
EPS Next 5YN/A
Revenue 1Y (TTM)1.7%
Revenue growth 3Y20.87%
Revenue growth 5Y14.66%
Sales Q2Q%3.19%
Revenue Next Year3.5%
Revenue Next 2Y3.49%
Revenue Next 3Y4.47%
Revenue Next 5YN/A
EBIT growth 1Y66.71%
EBIT growth 3Y19.94%
EBIT growth 5Y6.11%
EBIT Next Year62.99%
EBIT Next 3Y22.76%
EBIT Next 5YN/A
FCF growth 1Y646.7%
FCF growth 3Y6.48%
FCF growth 5Y25.95%
OCF growth 1Y321.69%
OCF growth 3Y11.16%
OCF growth 5Y21.73%